# First Tracks Biotherapeutics, Inc.: filings

TRAX · Nasdaq · CIK 2091349 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/trax.md) · [Financials](/companies/trax/financials.md) · [Filings](/companies/trax/filings.md) · [Insiders](/companies/trax/insiders.md)

## Reports and events: 12 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 34, 3 11, 8-K 8, 4/A 6, SCHEDULE 13G 5, 3/A 3, 424B3 3, 10-Q 2, DRS 2, EFFECT 2, S-1 2, 10-12B 1, 10-12B/A 1, 144 1, CERT 1, CORRESP 1, S-8 1, SEC STAFF ACTION 1, UPLOAD 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 07:37 ET | [S-1](/filings/0001193125-26-431033.md) | Registration statement | 0001193125-26-431033 |
| 2026-10-20 | 16:05 ET | [8-K](/filings/0001193125-26-426666.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-426666 |
| 2026-10-15 | 16:28 ET | [8-K](/filings/0001193125-26-422929.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-422929 |
| 2026-10-13 | 08:32 ET | [8-K](/filings/0001193125-26-419761.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-419761 |
| 2026-08-12 | 16:24 ET | [10-Q](/filings/0001193125-26-346931.md) | Quarterly report, period 2026-06-30 | 0001193125-26-346931 |
| 2026-08-12 | 16:19 ET | [8-K](/filings/0001193125-26-346908.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-346908 |
| 2026-06-22 | 16:05 ET | [8-K](/filings/0001193125-26-277504.md) | 1.01 Entry into a material agreement | 0001193125-26-277504 |
| 2026-05-14 | 16:32 ET | [10-Q](/filings/0001193125-26-224190.md) | Quarterly report, period 2026-03-31 | 0001193125-26-224190 |
| 2026-05-14 | 16:24 ET | [8-K](/filings/0001193125-26-224124.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-224124 |
| 2026-05-08 | 16:37 ET | [S-1](/filings/0001193125-26-214778.md) | Registration statement | 0001193125-26-214778 |
| 2026-04-20 | 17:23 ET | [8-K](/filings/0001193125-26-164328.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-164328 |
| 2026-04-03 | 19:40 ET | [8-K](/filings/0001193125-26-140835.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-140835 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 06:15 ET. No prices; not investment advice.